RNAC Market Cap & Key Metrics
Cartesian Therapeutics, Inc.
$6.82
+$0.14(+2.10%)
33
Overall
40
Value
30
Tech
31
Quality
Market Cap
$202.11M
Volume
214.39K
52W Range
$5.60 - $11.00
Target Price
$33.67
RNAC market cap is $202.11M. This page lists Cartesian Therapeutics, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
RNAC Key Metrics
- Market cap
- $202.11M
- EPS estimate, current year
- $-3.15
- EPS growth, 3-year
- -100.00%
- Value score
- 40
- Quality score
- 31
- Technical score
- 30
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $400.0K | $38.27M | $26.00M | $110.78M | $85.08M |
| EBITDA | -$135.76M | -$73.55M | -$234.01M | $40.05M | -$5.63M |
| EPS | $-5.02 | $-4.48 | $-49.80 | $7.20 | $-6.60 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RNAC | $6.82 | +2.1% | 214.39K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Cartesian Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW